BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29283381)

  • 1. Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment.
    Lin JC
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
    Pellagatti A; Boultwood J
    Adv Biol Regul; 2017 Jan; 63():59-70. PubMed ID: 27639445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
    Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
    Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant RNA splicing and therapeutic opportunities in cancers.
    Yamauchi H; Nishimura K; Yoshimi A
    Cancer Sci; 2022 Feb; 113(2):373-381. PubMed ID: 34812550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing-factor alterations in cancers.
    Anczuków O; Krainer AR
    RNA; 2016 Sep; 22(9):1285-301. PubMed ID: 27530828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
    Urbanski LM; Leclair N; Anczuków O
    Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Discovery of splicing inhibitors and its impact on drug development].
    Kotake Y; Kaida D; Mizui Y; Yoshida M
    Tanpakushitsu Kakusan Koso; 2008 Jan; 53(1):28-35. PubMed ID: 18186300
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms.
    Brierley CK; Steensma DP
    Curr Hematol Malig Rep; 2016 Dec; 11(6):408-415. PubMed ID: 27492253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splicing factors: Insights into their regulatory network in alternative splicing in cancer.
    Du JX; Zhu GQ; Cai JL; Wang B; Luo YH; Chen C; Cai CZ; Zhang SJ; Zhou J; Fan J; Zhu W; Dai Z
    Cancer Lett; 2021 Mar; 501():83-104. PubMed ID: 33309781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting splicing abnormalities in cancer.
    Agrawal AA; Yu L; Smith PG; Buonamici S
    Curr Opin Genet Dev; 2018 Feb; 48():67-74. PubMed ID: 29136527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers.
    Sahin I; George A; Seyhan AA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of alternative splicing in cancer.
    Singh B; Eyras E
    Transcription; 2017 Mar; 8(2):91-98. PubMed ID: 28005460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the spliceosome machinery: A new therapeutic axis in cancer?
    Eymin B
    Biochem Pharmacol; 2021 Jul; 189():114039. PubMed ID: 32417188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of splicing in cancer.
    Lee SC; Abdel-Wahab O
    Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.
    Mercatante DR; Sazani P; Kole R
    Curr Cancer Drug Targets; 2001 Nov; 1(3):211-30. PubMed ID: 12188880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs.
    Effenberger KA; Anderson DD; Bray WM; Prichard BE; Ma N; Adams MS; Ghosh AK; Jurica MS
    J Biol Chem; 2014 Jan; 289(4):1938-47. PubMed ID: 24302718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of chemoresistance via alternative messenger RNA splicing.
    Eblen ST
    Biochem Pharmacol; 2012 Apr; 83(8):1063-72. PubMed ID: 22248731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of RNA-Binding Proteins: Manipulate Alternative Splicing in Human Cells with Artificial Splicing Factors.
    Wang Y; Wang Z
    Methods Mol Biol; 2016; 1421():227-41. PubMed ID: 26965269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splicing Factor Mutations in Cancer.
    Bejar R
    Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.